Structural insights into engineering a T-cell receptor targeting MAGE-A10 with higher affinity and specificity for cancer immunotherapy

BACKGROUND: T-cell receptor (TCR) immunotherapy is becoming a viable modality in cancer treatment with efficacy in clinical trials. The safety of patients is paramount, so innovative cell engineering methods are being employed to exploit adaptive immunity while controlling the factors governing anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Simister, Philip C, Border, Ellen C, Vieira, João F, Pumphrey, Nicholas J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295655/
https://www.ncbi.nlm.nih.gov/pubmed/35851311
http://dx.doi.org/10.1136/jitc-2022-004600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295655/
https://www.ncbi.nlm.nih.gov/pubmed/35851311
http://dx.doi.org/10.1136/jitc-2022-004600

Ejemplares similares